Wells Fargo & Company Alpine Immune Sciences, Inc. Transaction History

Wells Fargo & Company

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.75 - $41.6 $58,397 - $136,864	3,290 Added 35.62%	12,526 $496,000
Q4 2023 Feb 09, 2024	BUY	$8.54 - $20.22 $18,796 - $44,504	2,201 Added 31.29%	9,236 $176,000
Q3 2023 Nov 13, 2023	SELL	$10.13 - $13.98 $57,193 - $78,931	-5,646 Reduced 44.52%	7,035 $80,000
Q2 2023 Aug 15, 2023	BUY	$6.84 - $11.91 $56,696 - $98,721	8,289 Added 188.73%	12,681 $130,000
Q1 2023 May 12, 2023	BUY	$7.0 - $8.75 $30,744 - $38,430	4,392 New	4,392 $33,000
Q3 2022 Nov 14, 2022	SELL	$6.89 - $9.39 $1,123 - $1,530	-163 Reduced 56.21%	127 $1,000
Q2 2022 Aug 12, 2022	SELL	$6.71 - $9.52 $36,321 - $51,531	-5,413 Reduced 94.91%	290 $2,000
Q1 2022 May 16, 2022	SELL	$6.41 - $13.89 $23,941 - $51,879	-3,735 Reduced 39.57%	5,703 $51,000
Q4 2021 Feb 14, 2022	SELL	$10.41 - $13.95 $473,030 - $633,888	-45,440 Reduced 82.8%	9,438 $130,000
Q3 2021 Nov 15, 2021	BUY	$8.19 - $11.31 $446,993 - $617,277	54,578 Added 18192.67%	54,878 $585,000
Q2 2021 Aug 16, 2021	SELL	$8.81 - $15.03 $581 - $991	-66 Reduced 18.03%	300 $3,000
Q1 2021 May 13, 2021	BUY	$10.02 - $13.92 $2,995 - $4,162	299 Added 446.27%	366 $4,000
Q4 2020 Feb 09, 2021	BUY	$7.42 - $15.96 $29 - $63	4 Added 6.35%	67 $1,000
Q3 2020 Nov 05, 2020	BUY	$7.15 - $11.5 $264 - $425	37 Added 142.31%	63 $1,000
Q1 2020 May 14, 2020	BUY	$2.15 - $4.41 $55 - $114	26 New	26 $0

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.